tiprankstipranks
Trending News
More News >
Anika Therapeutics (ANIK)
NASDAQ:ANIK
US Market
Advertisement

Anika Therapeutics (ANIK) Ratios

Compare
163 Followers

Anika Therapeutics Ratios

ANIK's free cash flow for Q1 2025 was $0.56. For the 2025 fiscal year, ANIK's free cash flow was decreased by $ and operating cash flow was $-0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.73 5.26 6.07 5.66 4.81
Quick Ratio
4.53 3.76 4.65 4.45 3.56
Cash Ratio
2.98 2.35 3.09 3.17 2.60
Solvency Ratio
-1.17 -1.17 0.02 0.33 -0.10
Operating Cash Flow Ratio
0.30 -0.06 0.16 0.28 0.35
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 60.30M$ 104.94M$ 105.98M$ 108.08M$ 84.18M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.11 0.09 0.06 0.06
Debt-to-Equity Ratio
0.17 0.14 0.11 0.07 0.08
Debt-to-Capital Ratio
0.15 0.12 0.10 0.06 0.07
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.28 1.27 1.22 1.21 1.34
Debt Service Coverage Ratio
0.00 0.00 -1.57 0.00 0.00
Interest Coverage Ratio
0.00 0.00 -29.66 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
1.78 1.98 2.17 1.34 1.47
Net Debt to EBITDA
-44.13 3.90 11.28 -28.74 5.84
Profitability Margins
Gross Profit Margin
62.58%61.85%59.89%56.12%52.91%
EBIT Margin
-6.08%-15.27%-12.42%-12.50%-11.09%
EBITDA Margin
0.60%-6.74%-3.14%1.77%-9.83%
Operating Profit Margin
-4.09%-52.58%-12.42%-12.50%-11.09%
Pretax Profit Margin
-2.05%-51.20%-12.00%1.64%-21.94%
Net Profit Margin
-53.76%-49.60%-9.51%2.80%-18.38%
Continuous Operations Profit Margin
-7.84%-49.60%-9.51%2.80%-18.38%
Net Income Per EBT
2624.61%96.88%79.26%170.33%83.78%
EBT Per EBIT
50.02%97.36%96.63%-13.13%197.84%
Return on Assets (ROA)
-29.77%-30.55%-4.26%1.19%-6.56%
Return on Equity (ROE)
-32.77%-38.95%-5.20%1.44%-8.80%
Return on Capital Employed (ROCE)
-2.50%-36.58%-6.04%-5.82%-4.40%
Return on Invested Capital (ROIC)
-9.47%-35.13%-4.76%-9.85%-3.67%
Return on Tangible Assets
-31.37%-31.99%-5.56%1.61%-9.01%
Earnings Yield
-36.08%-24.89%-3.45%0.80%-3.73%
Efficiency Ratios
Receivables Turnover
4.80 4.63 4.51 4.95 5.41
Payables Turnover
7.49 6.45 6.91 8.50 6.84
Inventory Turnover
1.85 1.37 1.58 1.80 1.33
Fixed Asset Turnover
1.61 2.22 1.98 2.16 1.78
Asset Turnover
0.55 0.62 0.45 0.43 0.36
Working Capital Turnover Ratio
1.21 1.22 1.11 1.06 0.72
Cash Conversion Cycle
224.42 288.47 259.67 233.42 288.61
Days of Sales Outstanding
76.03 78.76 80.90 73.70 67.43
Days of Inventory Outstanding
197.15 266.32 231.63 202.67 274.56
Days of Payables Outstanding
48.76 56.61 52.86 42.96 53.38
Operating Cycle
273.18 345.07 312.53 276.38 341.99
Cash Flow Ratios
Operating Cash Flow Per Share
0.38 -0.12 0.30 0.58 0.92
Free Cash Flow Per Share
-0.23 -0.49 -0.21 0.23 0.80
CapEx Per Share
0.61 0.37 0.51 0.36 0.11
Free Cash Flow to Operating Cash Flow
-0.62 4.04 -0.70 0.39 0.88
Dividend Paid and CapEx Coverage Ratio
0.62 -0.33 0.59 1.63 8.03
Capital Expenditure Coverage Ratio
0.62 -0.33 0.59 1.63 8.03
Operating Cash Flow Coverage Ratio
0.21 -0.06 0.14 0.44 0.63
Operating Cash Flow to Sales Ratio
0.05 -0.01 0.03 0.06 0.10
Free Cash Flow Yield
-2.12%-2.17%-0.71%0.63%1.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.78 -4.02 -29.01 124.82 -26.84
Price-to-Sales (P/S) Ratio
1.50 1.99 2.76 3.49 4.93
Price-to-Book (P/B) Ratio
1.06 1.56 1.51 1.80 2.36
Price-to-Free Cash Flow (P/FCF) Ratio
-47.25 -46.03 -140.07 158.57 56.28
Price-to-Operating Cash Flow Ratio
29.23 -185.74 97.76 61.45 49.27
Price-to-Earnings Growth (PEG) Ratio
3.57 >-0.01 0.06 -1.07 0.14
Price-to-Fair Value
1.06 1.56 1.51 1.80 2.36
Enterprise Value Multiple
206.00 -25.67 -76.44 168.58 -44.33
Enterprise Value
129.82M 288.27M 375.57M 440.84M 568.76M
EV to EBITDA
205.09 -25.67 -76.44 168.58 -44.33
EV to Sales
1.23 1.73 2.40 2.98 4.36
EV to Free Cash Flow
-38.74 -39.95 -122.06 135.48 49.73
EV to Operating Cash Flow
24.05 -161.23 85.18 52.50 43.53
Tangible Book Value Per Share
9.70 13.65 13.98 13.67 12.15
Shareholders’ Equity Per Share
10.38 14.48 19.61 19.94 19.15
Tax and Other Ratios
Effective Tax Rate
-2.83 0.03 0.21 -0.70 0.16
Revenue Per Share
7.38 11.37 10.73 10.26 9.17
Net Income Per Share
-3.97 -5.64 -1.02 0.29 -1.69
Tax Burden
26.25 0.97 0.79 1.70 0.84
Interest Burden
0.34 3.35 0.97 -0.13 1.98
Research & Development to Revenue
0.22 0.20 0.18 0.18 0.18
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.12 0.09 0.09 0.08 0.04
Income Quality
-0.10 0.02 -0.30 2.03 -0.54
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis